NCT05916924

Brief Summary

An observational study to collect (functional evaluation and daily motion) for composing 3D kinematic data that will be the basis for setting rehabilitation goal points for each stroke patient and developing virtual reality rehabilitation contents via video shooting.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 28, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 23, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

June 23, 2023

Status Verified

June 1, 2023

Enrollment Period

2.8 years

First QC Date

May 24, 2023

Last Update Submit

June 21, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Changes in motion analysis in gait spatiotemporal parameters

    Motion analysis is a process of measuring and evaluating gait function in gait spatiotemporal parameter, gait speed (m/s)

    Change from baseline to 1 day and 14 days

  • Changes in motion analysis in gait spatiotemporal parameters

    Motion analysis is a process of measuring and evaluating gait function in gait spatiotemporal parameter, stride length (cm)

    Change from baseline to 1 day and 14 days

  • Changes in motion analysis in kinematic parameters

    Motion analysis is a process of measuring and evaluating gait function in kinematic parameter, sagittal angle (degree)

    Change from baseline to 1 day and 14 days

Secondary Outcomes (3)

  • Changes in manual muscle test (MMT)

    Change from baseline to 1 day and 14 days

  • Changes in motricity index (MI)

    Change from baseline to 1 day and 14 days

  • Changes in berg balance scale (BBS)

    Change from baseline to 1 day and 14 days

Interventions

Collection of clinical data including manual muscle test (MMT), range of motion (ROM), Fugl-Meyer assessment (FMA), berg balance scale (BBS) and kinetic data via video shooting

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Stroke patients

You may qualify if:

  • Over 20 years of age
  • More than 1 month after onset of stroke
  • After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions

You may not qualify if:

  • Patients who correspond to one or more of the following cannot participate in the study.
  • Patients with systemic infectious symptoms at the time of participation in the study
  • In the case of a person with impaired ability to consent (less than 10 points on the MMSE), a person without a guardian
  • Those with severe medical conditions such as unstable conditions in the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with poor general health
  • Other cases where the researcher judges that participation in this study is not suitable (Patients who are participating in other studies or have participated in other studies within the past 30 days can also participate in this study.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rehabilitation Medicine, CHA Bundang Medical Center

Seongnam, 13496, South Korea

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

2-methylcyclopentadienyl manganese tricarbonylRange of Motion, Articular

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Physical ExaminationDiagnostic Techniques and ProceduresDiagnosisMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

May 24, 2023

First Posted

June 23, 2023

Study Start

March 28, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

June 23, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will share

Locations